Morpheus 8, a radiofrequency microneedling treatment, stimulates collagen production and tightens skin. While it’s generally safe for most people, it’s important to consider your potential diagnosis of scleroderma, an autoimmune condition that affects connective tissues, potentially leading to skin tightening, thickening, or fibrosis. Points to Consider: Raynaud's Phenomenon: As a symptom associated with scleroderma, it indicates heightened sensitivity in your microvasculature, which might increase the risk of adverse reactions like prolonged healing or poor circulation at the treatment site. Collagen Production: Scleroderma is characterized by overproduction of collagen in the skin and other tissues. Treatments like Morpheus 8, which stimulate collagen, could theoretically exacerbate localized skin changes in someone predisposed to this condition. Healing and Inflammation: People with scleroderma can experience slower wound healing and increased sensitivity to skin trauma. The micro-injuries created during microneedling might pose risks. Recommendations: Consult Your Rheumatologist: Before proceeding, discuss the planned treatment with your rheumatologist. They can offer insight into whether your condition or lab findings could increase risks. Communicate with Your Provider: Ensure the aesthetic provider administering the Morpheus 8 treatment is aware of your medical history. They might adjust the treatment depth, settings, or frequency to minimize potential complications. Monitor Closely: If you proceed, watch for delayed healing, increased redness, or other unusual skin changes after the treatment. While the absence of significant symptoms may be reassuring, your elevated antibody levels and Raynaud's suggest caution. A thorough discussion with your healthcare team is key to making the safest decision.